INTA Engages Chilean Industry, Government, and Business Published: December 9, 2020
INTA’s Latin America and the Caribbean Office in recent weeks held sessions on INTA’s study of Gen Z’s view on brands and counterfeits, artificial intelligence (AI) and intellectual property (IP), and IP protection for small businesses.
Gen Z Insights:
Brands and Counterfeit Products Study
José Luis Londoño, Chief Representative Officer, and Agustina Davis, Associate, for INTA’s Latin America and the Caribbean Office, attended a virtual meeting at the Illicit Trade Observatory of the Chilean Chamber of Commerce Services and Tourism (Chamber of Commerce) on November 26.
Ricardo Mewes, President of the Illicit Trade Observatory, welcomed the meeting attendees, who included representatives of public and private sector authorities.
news
A global threat heightened by Covid-19 The New Nation
photo by
Catherine Boudot
The latest report from the European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Co-operation and Development (OECD) highlights the dangers of counterfeit medicines for patients as well as the challenges posed by this form of illicit trade for governments and health care companies. The trend has only been exacerbated by the current health emergency created by Covid-19, with people worried about how to deal with this new unknown danger, which still has no approved vaccine or treatment, and the spread of potentially harmful fake products and medicines.